Previous Page  1696-1697 / 2351 Next Page
Information
Show Menu
Previous Page 1696-1697 / 2351 Next Page
Page Background

Xerostomia

Amifostine recommended by ASCO for RT but not for CRT.

d d h

d 2 f

% 3 % (

002)

- re uce c ronic xerostomia gra e rom 57 to 4

P

= .

.

Pilocarpine approved by FDA.

- N =249

- patients randomized between placebo versus pilocarpine 5 mgr

N=249

P-value

P

i

f li

f

i

P 0 05

reservat on o sa vary unct on

< .

Quality of life

P=NS

Gustatory stimuli (chewing, acid substance, saliva substitute, ..)

Buglione et al, Critical Reviews Oncology/hematology 2016

Hensley et al. JCO 2009

Fisher J Int J Radiat Oncol Biol Phys 2003